Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
StoneX Group Inc. Reports Fiscal 2024 Second Quarter Financial Results
-
Ballad Health, Niswonger Foundation Make Lifesaving Investment to Enhance Availability of Kidneys for Transplant, Reduce Costs of Care
-
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
-
Paycor Announces Third Quarter Fiscal Year 2024 Financial Results
-
Fossil Group, Inc. Reports First Quarter 2024 Financial Results
-
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
-
Black Hills Corp. Reports 2024 First-Quarter Results and Reaffirms 2024 Earnings Guidance
-
MRC Global Announces First Quarter 2024 Results
-
HP Inc. to Announce Second Quarter Fiscal 2024 Earnings on May 29, 2024
-
CoreCivic Reports First Quarter 2024 Financial Results
-
Alta Equipment Group Announces First Quarter 2024 Financial Results
-
FreightCar America, Inc. Reports First Quarter 2024 Results
-
Precision Optics Corporation Schedules Third Quarter of Fiscal Year 2024 Conference Call for Wednesday, May 15, 2024
-
Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference
-
Greenlight Re Announces First Quarter 2024 Financial Results
-
OMNIQ ANNOUNCES SUBMISSION OF APPLICATION TO OTCQX
-
The Honest Company Reports First Quarter 2024 Results
-
HCI Group Reports First Quarter 2024 Results
-
KRONOS WORLDWIDE, INC. REPORTS FIRST QUARTER 2024 RESULTS
-
Costco Wholesale Corporation Reports April Sales Results
-
CrossAmerica Partners LP Reports First Quarter 2024 Results
-
Dentsply Sirona to Participate in Upcoming Investor Conferences
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Intel Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – INTC
-
Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 5.750% Senior Unsecured Notes Due 2034
-
SiTime Reports First Quarter 2024 Financial Results
-
Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 5.750% Senior Unsecured Notes Due 2034
-
Profire Energy Reports Financial Results for First Quarter 2024
-
CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)
-
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
TEN Ltd. Announces the Filing of Form 20-F With the SEC
-
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
-
Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update
-
ContextLogic Inc. Reports First-Quarter 2024 Financial Results
-
Crescent Capital BDC, Inc. Reports First Quarter Net Investment Income Per Share of $0.63 and NAV Per Share of $20.28; Increases Quarterly Dividend
-
Taboola to Present in Upcoming Investor Conferences
-
Oculis Reports Q1 2024 Financial Results and Provides Company Updates
-
Opus One Gold Corporation Announces Private Placement of Up to $500,000
-
Anika Announces CFO Transition
-
P10 Provides Corporate Governance Updates
-
Lulus Announces Stock Repurchase Program
-
Context Therapeutics Reports First Quarter 2024 Operating and Financial Results
-
Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was to Participate in the 19th Annual Needham Technology, Media, & Consumer Conference
-
PennantPark Floating Rate Capital Ltd. Announces Financial Results for the Quarter Ended March 31, 2024
-
Anika Reports First Quarter 2024 Financial Results
-
PennantPark Investment Corporation Announces 14.3% Increase of Its Monthly Distribution to $0.08 per share and Financial Results for the Quarter Ended March 31, 2024
-
NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Surrozen Provides First Quarter 2024 Financial Results and Business Update
-
PetIQ, Inc. Reports First Quarter 2024 Financial Results
-
NextNav Inc. Reports First Quarter 2024 Results
-
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes

